当前位置：首页 > 文献互助 > 互助详情

Ruxolitinib复制

用户qgRSP4os3S6M 15天前 33 10 已完结

1. 系统已在2025-09-26 15:43:40对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

C Campas-Moya
Drugs of the Future, 2010
access.portico.org
… increase in the contribution from ruxolitinib metabolites to its activity. These results are also … different metabolites of ruxolitinib that show STAT3-inhibitory activity for these metabolites …

上一篇：Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study

下一篇：Efficient and selective dechlorination of chlorinated organic pollutants by cob(II)alamin and zero-valent iron

互助时间线

2025-09-19 16:34:35 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2025-09-19 15:43:40 [上传文件]

jodie0105上传了文件(pdf 91.05 KB), 求助状态变成 待确认

2025-09-19 15:15:07 [发起求助]

最新发布的求助

Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AML 10分钟前
What Is the Rate-Limiting Step of Oxygen Reduction Reaction on Fe–N–C Catalysts? 2小时前
MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment 2小时前
Synthetic methods for high-entropy nanomaterials 5小时前
Understanding the role of short- and long-range intermolecular interactions in novel computational drug discovery 5小时前
Synthesis of Novel SRPK1-Targeting Hybrid Compounds Incorporating Antimetabolites for Cancer Therapy 5小时前
Discovery of a First-in-Class SLIT2 Binder Disrupting the SLIT2/ROBO1 Axis via DNA-Encoded Library (DEL) Screening 5小时前
Topoisomerase II inhibitors in oncology: an updated patent review (2016-present) 5小时前
Toll-like receptor agonists as cancer therapeutics: a patent review (2014–2024) 5小时前
A patent review of MLKL modulators (2023 – present) 5小时前
The effect of high tibial osteotomy on osteoarthritis of the knee. An arthroscopic study of 54 knee joints 6小时前
Effects of a contusion load on spinal cord with different curvatures 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com